| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |